Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Stryker Corporation

SYKNYSE
Healthcare
Medical - Devices
$384.93
$12.27(3.29%)
U.S. Market is Open • 15:30

Stryker Corporation Fundamental Analysis

Stryker Corporation (SYK) shows moderate financial fundamentals with a PE ratio of 44.78, profit margin of 12.92%, and ROE of 15.04%. The company generates $25.1B in annual revenue with strong year-over-year growth of 10.23%.

Key Strengths

Operating Margin22.44%
Current Ratio1.89

Areas of Concern

Cash Position2.82%
PEG Ratio4.43
We analyze SYK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 72.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
72.8/100

We analyze SYK's fundamental strength across five key dimensions:

Efficiency Score

Weak

SYK struggles to generate sufficient returns from assets.

ROA > 10%
6.78%

Valuation Score

Weak

SYK trades at a premium to fair value.

PE < 25
44.78
PEG Ratio < 2
4.43

Growth Score

Moderate

SYK shows steady but slowing expansion.

Revenue Growth > 5%
10.23%
EPS Growth > 10%
-5.76%

Financial Health Score

Excellent

SYK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.66
Current Ratio > 1
1.89

Profitability Score

Moderate

SYK maintains healthy but balanced margins.

ROE > 15%
15.04%
Net Margin ≥ 15%
12.92%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is SYK Expensive or Cheap?

P/E Ratio

SYK trades at 44.78 times earnings. This suggests a premium valuation.

44.78

PEG Ratio

When adjusting for growth, SYK's PEG of 4.43 indicates potential overvaluation.

4.43

Price to Book

The market values Stryker Corporation at 6.48 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.48

EV/EBITDA

Enterprise value stands at 24.10 times EBITDA. This signals the market has high growth expectations.

24.10

How Well Does SYK Make Money?

Net Profit Margin

For every $100 in sales, Stryker Corporation keeps $12.92 as profit after all expenses.

12.92%

Operating Margin

Core operations generate 22.44 in profit for every $100 in revenue, before interest and taxes.

22.44%

ROE

Management delivers $15.04 in profit for every $100 of shareholder equity.

15.04%

ROA

Stryker Corporation generates $6.78 in profit for every $100 in assets, demonstrating efficient asset deployment.

6.78%

Following the Money - Real Cash Generation

Operating Cash Flow

Stryker Corporation produces operating cash flow of $5.05B, showing steady but balanced cash generation.

$5.05B

Free Cash Flow

Stryker Corporation generates strong free cash flow of $4.29B, providing ample flexibility for dividends, buybacks, or growth.

$4.29B

FCF Per Share

Each share generates $11.20 in free cash annually.

$11.20

FCF Yield

SYK converts 2.94% of its market value into free cash.

2.94%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

44.78

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

4.43

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.48

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.79

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.66

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.89

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.15

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.14

vs 25 benchmark

How SYK Stacks Against Its Sector Peers

MetricSYK ValueSector AveragePerformance
P/E Ratio44.7829.43 Worse (Expensive)
ROE15.04%800.00% Weak
Net Margin12.92%-20145.00% (disorted) Strong
Debt/Equity0.660.30 Weak (High Leverage)
Current Ratio1.894.64 Neutral
ROA6.78%-17936.00% (disorted) Weak

SYK outperforms its industry in 1 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Stryker Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

49.02%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

41.05%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

90.05%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ